FindTrial
Sign In

Use of mobile message for adherence to hypertension therapy

Mhealth intervention for adherence to antihypertensive treatment through mobile technology - Mhealth : mobile health

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2nf6xx
Enrollment
Unknown
Registered
2019-06-11
Start date
2017-10-23
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Experimental Group: 203 patients with diabetes and / or hypertension received 55 text messages, audio and images every other day for the WhatsApp application, over 16 weeks, with emphasis on drug adhe
Behavioural
Other
F01.100.150.750.500.600.500
N03.880

Sponsors

Centro Universitário de Maringá - UniCesumar
Lead Sponsor
Fundação Araucária
Collaborator

Eligibility

Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Being enrolled in the HiperDia system; making medical treatment for diabetes mellitus and or hypertension; being user of the WhatsApp app

Exclusion criteria

Exclusion criteria: Under 18 years old; more than 90 years; not having diabetes mellitus; not have hipertension; do not use WhatsApp app

Design outcomes

Primary

MeasureTime frame
To identify whether the messages text, audio and images sent by the WhatsApp app have educational effect to improve adherence to the drug therapy of diabetics and hypertensives enrolled in the Hiperdia system of the 33 Basic Health Units of Maringá - Paraná.—

Secondary

MeasureTime frame
To identify the level of adherence to the drug therapy of diabetics and hypertensives enrolled in the HiperDia system of the 33 Basic Health Units of Maringá - Paraná.—

Countries

Brazil

Contacts

Public ContactAmanda Sartori

Centro Universitário de Maringá - UniCesumar

amanddacarolline@hotmail.com+554430276360

Outcome results

None listed

Source: REBEC (via WHO ICTRP)